Related Experiment Videos
Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes
J Licinio1, M A Kling, P Hauser
1Clinical Neuroendocrinology Branch, National Institute of Mental Health, Bethesda, MD 20892-1284, USA.
Seminars in Oncology
|March 3, 1998
Summary
Interferon-alpha (IFN-alpha) cancer therapy can cause central nervous system (CNS) dysfunction, including mood and cognitive issues. This review explores the neurobiology of cytokines and their role in IFN-alpha-induced CNS side effects.
Area of Science:
- Neurobiology
- Immunology
- Oncology
Background:
- Interferon-alpha (IFN-alpha) is used as a biologic response modifier for cancer treatment.
- IFN-alpha therapy can lead to adverse central nervous system (CNS) effects, including mood and cognitive disturbances.
- Cytokine and receptor genes are expressed in the CNS, influencing brain function.
Purpose of the Study:
- To review the neurobiology of cytokines in the context of IFN-alpha therapy.
- To outline potential mechanisms of CNS dysfunction induced by IFN-alpha.
- To understand how cytokine alterations in the CNS contribute to mood and cognitive disorders.
Main Methods:
- Literature review of neurobiology and cytokine function.
- Analysis of cytokine expression in the CNS.
- Exploration of mechanisms linking cytokine activity to CNS dysfunction.
Main Results:
- IFN-alpha therapy's CNS effects are likely mediated by secondary cytokine cascades.
- Cytokines play a significant role in regulating brain functions.
- Alterations in CNS cytokine expression can precipitate mood and cognitive impairments.
Conclusions:
- IFN-alpha-induced CNS dysfunction is linked to complex cytokine interactions.
- Understanding cytokine neurobiology is crucial for managing IFN-alpha side effects.
- Further research into cytokine pathways may reveal therapeutic targets for CNS complications.